Literature DB >> 6340706

Prostaglandins and the cardiovascular system.

J R Vane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6340706      PMCID： PMC481324          DOI： 10.1136/hrt.49.5.405

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  49 in total

Review 1.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors:  S Moncada; J R Vane
Journal:  Pharmacol Rev       Date:  1978-09       Impact factor: 25.468

2.  Prostacyclin deficiency in thrombotic thrombocytopenic purpura.

Authors:  C N Hensby; P J Lewis; P Hilgard; G J Mufti; J Hows; J Webster
Journal:  Lancet       Date:  1979-10-06       Impact factor: 79.321

Review 3.  Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.

Authors:  S Moncada; J R Vane
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

4.  Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men.

Authors:  A Szczeklik; R J Gryglewski; R Nizankowski; J Musiał; R Pietoń; J Mruk
Journal:  Pharmacol Res Commun       Date:  1978-06

5.  Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.

Authors:  A M Lefer; M L Ogletree; J B Smith; M J Silver; K C Nicolaou; W E Barnette; G P Gasic
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

6.  Haemostasis disorders in open heart surgery with extracorporeal circulation. Importance of the platelet function and the heparin neutralization.

Authors:  M Moriau; R Masure; A Hurlet; C Debeys; C Chalant; R Ponlot; P Jaumain; Y Servaye-Kestens; A Ravaux; A Louis; M Goenen
Journal:  Vox Sang       Date:  1977       Impact factor: 2.144

7.  Platelet dysfunction associated with cardiopulmonary bypass.

Authors:  W R Friedenberg; W O Myers; E D Plotka; J N Beathard; D J Kummer; P F Gatlin; D L Stoiber; J F Ray; R D Sautter
Journal:  Ann Thorac Surg       Date:  1978-04       Impact factor: 4.330

8.  Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.

Authors:  J J Belch; A McKay; B McArdle; P Leiberman; J G Pollock; G D Lowe; C D Forbes; C R Prentice
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

9.  Prostacyclin can replace heparin in haemodialysis in dogs.

Authors:  H F Woods; G Ash; M J Weston; S Bunting; S Moncada; J R Vane
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

10.  Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.

Authors:  A Szczeklik; R Nizankowski; S Skawinski; J Szczeklik; P Gluszko; R J Gryglewski
Journal:  Lancet       Date:  1979-05-26       Impact factor: 79.321
View more
  9 in total

Review 1.  Cellular and humoral mediators of pulmonary edema.

Authors:  A B Malik; W M Selig; K E Burhop
Journal:  Lung       Date:  1985       Impact factor: 2.584

2.  Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2.

Authors:  Rui Yu; Lei Xiao; Guiqing Zhao; John W Christman; Richard B van Breemen
Journal:  J Pharmacol Exp Ther       Date:  2011-08-24       Impact factor: 4.030

Review 3.  The zone diet and athletic performance.

Authors:  S N Cheuvront
Journal:  Sports Med       Date:  1999-04       Impact factor: 11.136

4.  Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.

Authors:  Y Yui; T Aoyama; H Morishita; M Takahashi; Y Takatsu; C Kawai
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

5.  Increased hydrolysis of cholesteryl ester with prostacyclin is potentiated by high density lipoprotein through the prostacyclin stabilization.

Authors:  H Morishita; Y Yui; R Hattori; T Aoyama; C Kawai
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Cyclosporin reduces renal prostanoid excretion in type 1 diabetic patients.

Authors:  V A Koivisto; M Leirisalo-Repo; R Pelkonen; U Turunen; J Rapola; L Viinikka; O Ylikorkala
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

Review 7.  [Eicosanoids and phospholipases].

Authors:  M Goerig; A J Habenicht; G Schettler
Journal:  Klin Wochenschr       Date:  1985-04-01

8.  Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.

Authors:  C Ribuot; L Rochette
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

9.  Method development and validation for ultra-high pressure liquid chromatography/tandem mass spectrometry determination of multiple prostanoids in biological samples.

Authors:  Rui Yu; Guiqing Zhao; John W Christman; Lei Xiao; Richard B Van Breemen
Journal:  J AOAC Int       Date:  2013 Jan-Feb       Impact factor: 1.913
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.